Felipe Slebe

646 total citations
8 papers, 204 citations indexed

About

Felipe Slebe is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Felipe Slebe has authored 8 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Rheumatology. Recurrent topics in Felipe Slebe's work include Glycogen Storage Diseases and Myoclonus (2 papers), RNA modifications and cancer (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Felipe Slebe is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (2 papers), RNA modifications and cancer (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Felipe Slebe collaborates with scholars based in Spain, Chile and United States. Felipe Slebe's co-authors include Mar Garcı́a-Rocha, Joan J. Guinovart, Giorgia Testoni, Jordi Durán, Mitchell A. Sullivan, David Sebastián, Marta Vilaseca, Pura Muñoz‐Cánoves, Francisco Vilaplana and Iliana López‐Soldado and has published in prestigious journals such as Nature Communications, Cell Metabolism and Cell stem cell.

In The Last Decade

Felipe Slebe

8 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Felipe Slebe Spain 7 98 45 44 36 32 8 204
Jiantuan Xiong China 10 191 1.9× 64 1.4× 99 2.3× 16 0.4× 16 0.5× 17 318
Rana Chakrabarti Canada 5 146 1.5× 39 0.9× 8 0.2× 25 0.7× 15 0.5× 7 227
Xuezhen Xuan China 4 120 1.2× 46 1.0× 14 0.3× 15 0.4× 12 0.4× 9 299
Edlira Luca Switzerland 9 113 1.2× 56 1.2× 29 0.7× 19 0.5× 11 0.3× 16 242
Leigh Ann Perkins United States 7 191 1.9× 52 1.2× 12 0.3× 78 2.2× 23 0.7× 7 359
Fabienne Parente France 8 76 0.8× 29 0.6× 14 0.3× 60 1.7× 8 0.3× 12 174
Zhenhua Li China 11 186 1.9× 113 2.5× 10 0.2× 22 0.6× 34 1.1× 21 319
Zihong Chen United States 4 172 1.8× 84 1.9× 16 0.4× 9 0.3× 15 0.5× 6 237
Wenhui Zhao China 13 262 2.7× 137 3.0× 20 0.5× 16 0.4× 60 1.9× 46 401
Zhenping Chen United States 6 226 2.3× 88 2.0× 10 0.2× 19 0.5× 72 2.3× 10 327

Countries citing papers authored by Felipe Slebe

Since Specialization
Citations

This map shows the geographic impact of Felipe Slebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felipe Slebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felipe Slebe more than expected).

Fields of papers citing papers by Felipe Slebe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felipe Slebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felipe Slebe. The network helps show where Felipe Slebe may publish in the future.

Co-authorship network of co-authors of Felipe Slebe

This figure shows the co-authorship network connecting the top 25 collaborators of Felipe Slebe. A scholar is included among the top collaborators of Felipe Slebe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felipe Slebe. Felipe Slebe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Marhold, Maximilian, Marta Vaz Batista, Isabel Blancas, et al.. (2025). TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases. Future Oncology. 21(9). 1065–1073. 2 indexed citations
2.
Quintana, Ángela, Kamal S. Saini, Laura Vidal, et al.. (2024). Window of opportunity trials with immune checkpoint inhibitors in triple-negative breast cancer. ESMO Open. 9(10). 103713–103713. 7 indexed citations
3.
Morral, Clara, Jelena Stanisavljević, Xavier Hernando‐Momblona, et al.. (2020). Zonation of Ribosomal DNA Transcription Defines a Stem Cell Hierarchy in Colorectal Cancer. Cell stem cell. 26(6). 845–861.e12. 49 indexed citations
4.
Testoni, Giorgia, Jordi Durán, Mar Garcı́a-Rocha, et al.. (2017). Lack of Glycogenin Causes Glycogen Accumulation and Muscle Function Impairment. Cell Metabolism. 26(1). 256–266.e4. 67 indexed citations
5.
Durán, Jordi, Felipe Slebe, Mar Garcı́a-Rocha, et al.. (2016). Genetic models rule out a major role of beta cell glycogen in the control of glucose homeostasis. Diabetologia. 59(5). 1012–1020. 11 indexed citations
6.
Slebe, Felipe, Federico Rojo, María Vinaixa, et al.. (2016). FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth. Nature Communications. 7(1). 11199–11199. 43 indexed citations
7.
Maldonado, R., Héctor Mancilla, Franz Villarroel‐Espíndola, et al.. (2016). Glycogen Synthase in Sertoli Cells: More Than Glycogenesis?. Journal of Cellular Biochemistry. 117(11). 2597–2607. 6 indexed citations
8.
Bertinat, Romina, Felipe Slebe, Fabián Pardo, et al.. (2014). Over-expression of muscle glycogen synthase in human diabetic nephropathy. Histochemistry and Cell Biology. 143(3). 313–324. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026